- Autism
- Autoimmune Diseases
- Cosmetic, Anti-Aging, and Skin Health
- Chronic Pain
- Gastrointestinal Disorders
- Multiple Sclerosis
- Neurological Conditions
- Orthopedic and Sports Injury
- Osteoarthritis
- Rheumatoid Arthritis
- Sexual Wellness and ED
- Spine and Disc Conditions and Back Pain
- Spinal Cord Injuries
- Traumatic Brain Injury (TBI)
- This event has passed.
IOF MAX with TOBI 2026 – 11th Annual Conference for The Interventional Orthobiologics Foundation
June 17 @ 8:00 am - June 20 @ 5:00 pm
IOF MAX with TOBI – 11th Annual Conference for The Interventional Orthobiologics Foundation
Dr. Karolynn Halpert, Chief Medical Officer of BioXcellerator will attend the IOF MAX with TOBI, this is the 11th annual conference for the Interventional Orthobiologics Foundation at the Gaylord Rockies in Denver, CO where she will share clinical insights and key findings from BioXcellerator’s ongoing work in regenerative medicine and stem cell therapy.
The Interventional Orthobiologics Foundation (IOF) MAX is an annual conference designed to bring together clinicians, researchers, and innovators in regenerative medicine and orthobiologics. The event combines didactic lectures, interactive sessions, and hands-on labs to advance clinical knowledge and treatment strategies.
IOF MAX with TOBI 2026, is offering an expanded venue and immersive educational experience. For more information visit interventionalorthobiologics.org
Features:
- Didactic Talks & Interactive Q&A: Dynamic presentations from global experts focus on clinical innovation, evidence-based practice, and practical skills.
- Hands-On Labs: Curriculum-based workshops allow attendees to practice and refine techniques in orthobiologics.
- Networking & Collaboration: The conference fosters professional connections, mentorship, and exposure to research opportunities.
- Venue & Experience: Set against the Rocky Mountains, the conference offers a family-friendly resort setting, on-site dining, and opportunities for outdoor activities like hiking.
Details:
- Presenter: Dr. Karolynn Halpert (BioXcellerator’s Chief Medical Officer)
- Title: “Culture-Expanded Wharton’s Jelly MSCs in Tendinopathies: Safety and Real-World Clinical Outcomes in 532 Patients”
- Presentation Date: Friday, June 19th, 2026
- Presentation Time: 4:45pm
- IOF MAX with TOBI 2026 Event Dates: June 17–20, 2026
For more information about Dr. Karolynn Halpert and BioXcellerator’s contributions to regenerative medicine—or to schedule a meeting during IOF MAX with TOBI—contact us.
